S199: A PHASE 3, OPEN-LABEL, RANDOMIZED STUDY EVALUATING THE EFFICACY AND SAFETY OF SINGLE AGENT BELANTAMAB MAFODOTIN VS POMALIDOMIDE PLUS DEXAMETHASONE IN RELAPSED/REFRACTORY MULTIPLE MYELOMA (DREAMM-3)

Authors: Meletios A. Dimopoulos, Vania Hungria, Atanas Radinoff, Sosana Delimpasi, Gabor Mikala, Tamas Masszi, Jian LI, Marcelo Eduardo Capra, Morio Matsumoto, Neal Sule, Mary LI, Astrid Mckeown, Wei He, Shelley Bright, Brooke Currie, Julia Boyle, Joanna Opalinska, Katja Weisel

Source: HemaSphere, Vol 7, p e072005a (2023)

Subject Terms: Diseases of the blood and blood-forming organs, RC633-647.5

File Description: electronic resource

Relation: http://journals.lww.com/10.1097/01.HS9.0000967708.07200.5a; https://doaj.org/toc/2572-9241

Access URL: https://doaj.org/article/9191e9fdb2564bc3afaf1af09b250cca

P1245: PARALLEL TESTING OF LIQUID BIOPSY (CTDNA) AND TISSUE BIOPSY SAMPLES REVEALS A HIGHER FREQUENCY OF TARGETABLE EZH2 MUTATIONS IN FOLLICULAR LYMPHOMA

Authors: Bence Bátai, Ákos Nagy, Laura Kiss, Stefánia Gróf, Péter Attila Király, Ádám Jóna, Judit Demeter, Hermina Santa, Arpad Batai, Piroska Pettendi, Tamás Szendrei, Márk Béla Plander, Gábor Kőrösmezey, Hussain Alizadeh, Béla Kajtár, Gábor Méhes, László Krenács, Botond Timár, Judit Csomor, Erika Tóth, Tamás Schneider, Gabor Mikala, András Matolcsy, Donat Alpar, András Masszi, Csaba Bödör

Source: HemaSphere, Vol 7, p e303289c (2023)

Subject Terms: Diseases of the blood and blood-forming organs, RC633-647.5

File Description: electronic resource

Relation: http://journals.lww.com/10.1097/01.HS9.0000971872.30328.9c; https://doaj.org/toc/2572-9241

Access URL: https://doaj.org/article/fe1f54764a91430ab1d604497e34a641

Phase II trials of zilucoplan in paroxysmal nocturnal hemoglobinuria

Authors: Austin G. Kulasekararaj, Anna-Elina Lehtinen, Cecily Forsyth, Shreyans Gandhi, Morag Griffin, Sixten Körper, Gabor Mikala, Petra Muus, Ulrik Overgaard, Christopher J. Patriquin, Humphrey Pullon, Yu-Min Shen, Ruth Spearing, Jeff Szer, Guillemette de la Borderie, Petra W. Duda, Ramin Farzaneh-Far, Sharan Ragunathan, Camil E. Sayegh, Douangsone D. Vadysirisack, Hubert Schrezenmeier

Source: Haematologica, Vol 109, Iss 3 (2023)

Subject Terms: Diseases of the blood and blood-forming organs, RC633-647.5

File Description: electronic resource

Relation: https://haematologica.org/article/view/11186; https://doaj.org/toc/0390-6078; https://doaj.org/toc/1592-8721

Access URL: https://doaj.org/article/a6d39a02ce5f4b1dae4e88e54d1607c1

ISATUXIMAB PLUS CARFILZOMIB AND DEXAMETHASONE IN PATIENTS WITH RELAPSED MULTIPLE MYELOMA AND SOFT-TISSUE PLASMACYTOMAS: IKEMA SUBGROUP ANALYSIS

Authors: Mehmut TURGUT, Roman HAJEK, Tomas JELÍNEK, Philippe MOREAU, Thomas MARTIN, Ludek POUR, Gabor MIKALA, Argiris SYMEONIDIS, Sara BRINGHEN, Andreea RAWLINGS, Marie Laure RISSE, Helgi VAN DE VELDE, Ivan SPICKA

Source: Hematology, Transfusion and Cell Therapy, Vol 43, Iss , Pp S18- (2021)

Subject Terms: Diseases of the blood and blood-forming organs, RC633-647.5

File Description: electronic resource

Relation: http://www.sciencedirect.com/science/article/pii/S2531137921011226; https://doaj.org/toc/2531-1379

Access URL: https://doaj.org/article/3c2d6faeced74604914a15ac633f598e

Plasma Cell Leukemia – Facts and Controversies: More Questions than Answers?

Authors: Anna Suska, David H. Vesole, Jorge J. Castillo, Shaji K. Kumar, Hari Parameswaran, Maria V. Mateos, Thierry Facon, Alessandro Gozzetti, Gabor Mikala, Marta Szostek, Joseph Mikhael, Roman Hajek, Evangelos Terpos, Artur Jurczyszyn

Source: Clinical Hematology International, Vol 2, Iss 4 (2020)

Subject Terms: Plasma cell leukemia, plasma cell dyscrasia, chemotherapy, novel agents, stem cell transplantation, clinical trials, Diseases of the blood and blood-forming organs, RC633-647.5

File Description: electronic resource

Relation: https://www.atlantis-press.com/article/125941885/view; https://doaj.org/toc/2590-0048

Access URL: https://doaj.org/article/3214463ef5414175942165bf4bb32396

Heterogenous mutation spectrum and deregulated cellular pathways in aberrant plasma cells underline molecular pathology of light-chain amyloidosis

Authors: Zuzana Chyra, Tereza Sevcikova, Petr Vojta, Janka Puterova, Lucie Brozova, Katerina Growkova, Jana Filipova, Martina Zatopkova, Sebastian Grosicki, Agnieszka Barchnicka, Wieslaw Wiktor Jedrzejczak, Anna Waszczuk-Gajda, Alexandra Jungova, Aneta Mikulasova, Marian Hajduch, Martin Mokrejs, Ludek Pour, Martin Stork, Lubica Harvanova, Martin Mistrik, Gabor Mikala, Pawel Robak, Anna Czyz, Jakub Debski, Lidia Usnarska-Zubkiewicz, Artur Jurczyszyn, Lukas Stejskal, Gareth Morgan, Fedor Kryukov, Eva Budinska, Michal Simicek, Tomas Jelinek, Matous Hrdinka, Roman Hajek

Source: Haematologica, Vol 106, Iss 2 (2020)

Subject Terms: Diseases of the blood and blood-forming organs, RC633-647.5

File Description: electronic resource

Relation: https://haematologica.org/article/view/9744; https://doaj.org/toc/0390-6078; https://doaj.org/toc/1592-8721

Access URL: https://doaj.org/article/8ca446e23b564678a7535e85cd1ee3ce

MM-509 A Phase III, Open-Label, Randomized Study to Evaluate the Efficacy and Safety of Single-Agent Belantamab Mafodotin (Belamaf) Compared With Pomalidomide Plus Low-Dose Dexamethasone (Pd) in Patients With Relapsed or Refractory Multiple Myeloma (RRMM) (DREAMM-3)

Authors: Weisel, Katja, Hungria, Vania T.M., Radinoff, Atanas, Delimpasi, Sosana, Gabor, Mikala, Masszi, Tamas, Li, Jian, Capra, Marcelo, Matsumoto, Morio, Sule, Neal, Li, Mary, McKeown, Astrid, He, Wei, Bright, Shelley, Currie, Brooke, Boyle, Julia, Opalinska, Joanna, Dimopoulos, Meletios Athanasios

Source: Clinical lymphoma, myeloma & leukemia. 23(S1):S504-S505

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100196309273.0x000001&indx=1&recIds=ETOCvdc_100196309273.0x000001

POSTER: MM-509 A Phase III, Open-Label, Randomized Study to Evaluate the Efficacy and Safety of Single-Agent Belantamab Mafodotin (Belamaf) Compared With Pomalidomide Plus Low-Dose Dexamethasone (Pd) in Patients With Relapsed or Refractory Multiple Myeloma (RRMM) (DREAMM3)

Authors: Weisel, Katja, Hungria, Vania T.M., Radinoff, Atanas, Delimpasi, Sosana, Gabor, Mikala, Masszi, Tamas, Li, Jian, Capra, Marcelo, Matsumoto, Morio, Sule, Neal, Li, Mary, McKeown, Astrid, He, Wei, Bright, Shelley, Currie, Brooke, Boyle, Julia, Opalinska, Joanna, Dimopoulos, Meletios Athanasios

Source: Clinical lymphoma, myeloma & leukemia. 23(S1):S223-S223

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100196317574.0x000001&indx=1&recIds=ETOCvdc_100196317574.0x000001

Delayed Onset of Thrombotic Microangiopathy (TMA) upon Prolonged Carfilzomib Therapy in Multiple Myeloma: A Case Report and Comprehensive Review

Authors: Andrea Ceglédi, Ágnes Király, Andrea Várkonyi, Szabolcs Tasnády, Hajnalka Andrikovics, Mónika Fekete, Bálint G. Szabó, Zsuzsanna Szemlaky, Ágnes Szilágyi, György Sinkovits, Zoltán Prohászka, Marienn Réti, Gábor Mikala

Source: Pharmaceuticals, Vol 17, Iss 12, p 1722 (2024)

Subject Terms: thrombotic microangiopathy, carfilzomib, multiple myeloma, plasmapheresis, delayed onset, Medicine, Pharmacy and materia medica, RS1-441

File Description: electronic resource

Relation: https://www.mdpi.com/1424-8247/17/12/1722; https://doaj.org/toc/1424-8247

Access URL: https://doaj.org/article/2831d34d6047484686e90d4b121f051d

Case Report: Effective management of adalimumab-induced acquired hemophilia A with the CyDRI protocol

Authors: Andrea Ceglédi, Árpád Bátai, János Dolgos, Mónika Fekete, László Gopcsa, Viktória Király, Gergely Lakatos, György Nagy, Zsuzsanna Szemlaky, Andrea Várkonyi, Beáta Vilimi, Gábor Mikala, Imre Bodó

Source: Pathology and Oncology Research, Vol 30 (2024)

Subject Terms: adalimumab, acquired hemophilia A, bleeding disorder, immunosuppression, rheumatoid arthritis, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282, Pathology, RB1-214

File Description: electronic resource

Relation: https://www.por-journal.com/articles/10.3389/pore.2024.1611720/full; https://doaj.org/toc/1532-2807

Access URL: https://doaj.org/article/f43d9bfbb18044cebdc9ea01646dc51e

Effective venetoclax-based treatment in relapsed/refractory multiple myeloma patients with translocation t(6;14)

Authors: Andrea Ceglédi, Zoltán Csukly, Mónika Fekete, András Kozma, Zsuzsanna Szemlaky, Hajnalka Andrikovics, Gábor Mikala

Source: Pathology and Oncology Research, Vol 29 (2023)

Subject Terms: multiple myeloma, venetoclax, translocation t(6, 14), IGH::CCND3, personalized therapy, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282, Pathology, RB1-214

File Description: electronic resource

Relation: https://www.por-journal.com/articles/10.3389/pore.2023.1611375/full; https://doaj.org/toc/1532-2807

Access URL: https://doaj.org/article/f1942aab14334e64bc29fb8dba190576

This result is not displayed to guests.
Login for full access.

Delayed spontaneous remission of acquired factor V inhibitor refractory to immunosuppressive therapy with pregnancy-associated improvement

Authors: Andrea Ceglédi, János Dolgos, Mónika Fekete, László Gopcsa, Andrea Várkonyi, Beáta Vilimi, Gábor Mikala, Imre Bodó

Source: Pathology and Oncology Research, Vol 29 (2023)

Subject Terms: factor V inhibitor, coagulopathy, gestation, bleeding disorder, autoimmune, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282, Pathology, RB1-214

File Description: electronic resource

Relation: https://www.por-journal.com/articles/10.3389/pore.2023.1611250/full; https://doaj.org/toc/1532-2807

Access URL: https://doaj.org/article/f3fb4d10ceb74643a485e64375a24cf0

Liquid biopsy-based monitoring of residual disease in multiple myeloma by analysis of the rearranged immunoglobulin genes-A feasibility study.

Authors: Anita Marx, Magdolna Osváth, Bence Szikora, Orsolya Pipek, István Csabai, Ákos Nagy, Csaba Bödör, Zsolt Matula, Ginette Nagy, András Bors, Ferenc Uher, Gábor Mikala, István Vályi-Nagy, Imre Kacskovics

Source: PLoS ONE, Vol 18, Iss 5, p e0285696 (2023)

Subject Terms: Medicine, Science

File Description: electronic resource

Relation: https://doaj.org/toc/1932-6203

Access URL: https://doaj.org/article/72c26859dca34bd784adcddfb998a56a

Pomalidomide Treatment in Relapsed/Refractory Multiple Myeloma Patients—Real-World Data From Hungary

Authors: Szilvia Lovas, Nóra Obajed Al-Ali, Gergely Varga, Virág Szita, Hussain Alizadeh, Márk Plander, Péter Rajnics, Árpád Illés, Zsuzsa Szemlaky, Gábor Mikala, László Váróczy

Source: Pathology and Oncology Research, Vol 28 (2022)

Subject Terms: survival, toxicity, multiple myeloma, treatment response, pomalidomide, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282, Pathology, RB1-214

File Description: electronic resource

Relation: https://www.por-journal.com/articles/10.3389/pore.2022.1610645/full; https://doaj.org/toc/1532-2807

Access URL: https://doaj.org/article/108b0d10eefe48f3bdd373b674f12ec2

Revealing a Phenotypical Appearance of Ibrutinib Resistance in Patients With Chronic Lymphocytic Leukaemia by Flow Cytometry

Authors: Ferenc Takács, Lili Kotmayer, Ágnes Czeti, Gábor Szalóki, Tamás László, Gábor Mikala, Ágnes Márk, András Masszi, Péter Farkas, Márk Plander, Júlia Weisinger, Judit Demeter, Sándor Fekete, László Szerafin, Beáta Margit Deák, Erika Szaleczky, Adrienn Sulák, Zita Borbényi, Gábor Barna

Source: Pathology and Oncology Research, Vol 28 (2022)

Subject Terms: flow cytometry, targeted therapy, drug resistance, chronic lymphocytic leukaemia, ibrutinib, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282, Pathology, RB1-214

File Description: electronic resource

Relation: https://www.por-journal.com/articles/10.3389/pore.2022.1610659/full; https://doaj.org/toc/1532-2807

Access URL: https://doaj.org/article/67ee4bfac9474d47bbb380f327109d94

This result is not displayed to guests.
Login for full access.

Nucleophosmin1 and isocitrate dehydrogenase 1 and 2 as measurable residual disease markers in acute myeloid leukemia.

Authors: Petra Kövy, Zoltán Őrfi, András Bors, András Kozma, László Gopcsa, János Dolgos, Nóra Lovas, József Harasztdombi, Viktor Lakatos, Ágnes Király, Gábor Mikala, István Vályi-Nagy, Péter Reményi, Hajnalka Andrikovics

Source: PLoS ONE, Vol 16, Iss 6, p e0253386 (2021)

Subject Terms: Medicine, Science

File Description: electronic resource

Relation: https://doaj.org/toc/1932-6203

Access URL: https://doaj.org/article/a29c4b9b870e4ce6a27101d22d6b7a81

Ocular Signs and Ocular Comorbidities in Monoclonal Gammopathy: Analysis of 80 Subjects

Authors: Kitti Kormányos, Klaudia Kovács, Orsolya Németh, Gábor Tóth, Gábor László Sándor, Anita Csorba, Cecília Nóra Czakó, Achim Langenbucher, Zoltán Zsolt Nagy, Gergely Varga, László Gopcsa, Gábor Mikala, Nóra Szentmáry

Source: Journal of Ophthalmology, Vol 2021 (2021)

Subject Terms: Ophthalmology, RE1-994

File Description: electronic resource

Relation: https://doaj.org/toc/2090-004X; https://doaj.org/toc/2090-0058

Access URL: https://doaj.org/article/b6f2b4662fa3434ca0189a239933844a

Decreased Plasma Level of Cytokeratin 20 (KRT20) Is Indicative of the Emergence and Severity of Acute GvHD Irrespective to the Type of Organ Involvement

Authors: Nikolett Lupsa, Ákos Szegedi, András Gézsi, Zoltán Vuncs, Tamás Masszi, Gábor Mikala, Péter Reményi, Sara Deola, Arun Prasath Lakshmanan, Annalisa Terranegra, Edit I. Buzás, Zoltán Pós

Source: Biomedicines, Vol 10, Iss 3, p 519 (2022)

Subject Terms: acute graft versus host disease, aGvHD, biomarker, cytokeratin 20, KRT20, K20, Biology (General), QH301-705.5

File Description: electronic resource

Relation: https://www.mdpi.com/2227-9059/10/3/519; https://doaj.org/toc/2227-9059

Access URL: https://doaj.org/article/0d89a4d6012a44959be5fafce3e029c8